Company: IONQ
Filing Date: 2025-08-28
Form Type: 424B7
Source: 0001193125-25-191228
Chunk: 5

Company: IonQ, Inc.
Filing Date: 2025-08-28
Form: 424B7
Chunk 5
---
3

RISK FACTORS

Investing in our securities involves a high degree of risk. Before making a decision to invest in our securities, in addition to carefully considering the other information contained in this prospectus supplement, in the accompanying prospectus and in the documents incorporated by reference herein or therein, you should carefully consider the risks described below, as well as the risks discussed under the caption “Risk Factors” contained in our most recent Annual Report on Form 10-Kand any subsequent Quarterly Reports on Form 10-Q,each as amended or updated by our subsequent filings with the SEC, which are incorporated by reference into this prospectus supplement in their entirety. The risks described in these documents are not the only ones we face. There may be other unknown or unpredictable economic, business, competitive, regulatory or other factors that could harm our future results. Past financial performance may not be a reliable indicator of future performance, and historical trends should not be used to anticipate results or trends in future periods. If any of these risks actually occurs, our business, financial condition, results of operations or prospects could be harmed. This could cause the trading price of our common stock to decline, resulting in a loss of all or part of your investment. Please also read carefully the section below titled “Forward-Looking Statements.”

Additional Risks Related to the Offering

Future sales or issuances of our common stock in the public markets, including sales by the selling stockholders, or sales by our directors and officers, or the perception of such sales, could depress the trading price of our common stock.

The sale of a substantial number of shares of our common stock or other equity-related securities in the public markets, or the perception that
such sales could occur, could depress the market price of our common stock and impair our ability to raise capital through the sale of additional equity securities. We or selling stockholders may sell large quantities of our common stock at any time
pursuant to this prospectus supplement or in one or more separate offerings. The number of shares, if any, that are sold by the selling stockholders under this prospectus supplement will fluctuate based on a number of factors, including the market
price of our common stock and the demand for our common stock during the sales period and we cannot predict the number of shares of our common stock that will be sold.

With the exception of a period that started on July 7, 2025 and will end on September 5, 2025, during which our directors and
officers are subject